| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |